Who invested in Cartesian Therapeutics?
Cartesian Therapeutics's investors include Invus and National Heart, Lung and Blood Institute.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$180Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $130M sold, first sale Jul 2024
From Cartesian Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cartesian Therapeutics's investors include Invus and National Heart, Lung and Blood Institute.
Cartesian Therapeutics has raised $180M across 2 rounds since 2024.
Cartesian Therapeutics's most recent round was a Debt of $50M in May 2026.
Cartesian Therapeutics's largest round on record is $130M (Undisclosed round), in Jul 2024.
Cartesian Therapeutics's first round on record, in Jul 2024, was backed by Invus and National Heart, Lung and Blood Institute.
Cartesian Therapeutics's latest named round is a Debt, in May 2026.
Cartesian Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.